ConductScience.org, home

Paper38726720

Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.

Garot P and 30 others. EuroIntervention, 2024. Cited by 19 papers, by iCite.

Cite this record

ConductScience Library. Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document. Papers, record 38726720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38726720

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document.
PubMed
Journal
EuroIntervention
PubMed
Year
2024
PubMed
Publication types
Journal Article, Consensus Statement
PubMed
Citations, by iCite
19
iCite
Relative citation ratio, by iCite
2.49, provisional
iCite
Revised in PubMed
2026-01-20
PubMed

Authors31

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Garot PPhilippe
2Morice MCMarie-Claude
3Angiolillo DJDominick J
4Cabau JRJosep Rodés-
5Park DWDuk-Woo
6Van Mieghem NMNicolas M
7Collet JPJean-Philippe
8Leon MBMartin B
9Sengottuvelu GGunasekaran
10Neylon AAntoinette
11Ten Berg JMJurrien M
12Mylotte DDarren
13Tchétché DDidier
14Krucoff MWMitchell W
15Reardon MJMichael J
16Piazza NNicolo
17Mack MJMichael J
18Généreux PPhilippe
19Makkar RRaj
20Hayashida KKentaro

Source PubMed

See all 31 authorsDownload CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Transcatheter Aortic Valve ReplacementMajor topic
HemorrhageMajor topic
Humans
Risk Factors
Risk Assessment
Aortic Valve Stenosis
Aortic Valve

Source PubMed

Download CSV of topics

References131

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136130256The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties.Eur Heart J2022https://conductscience.org/library/papers/36130256PubMed
228315573Mortality, Length of Stay, and Cost Implications of Procedural Bleeding After Percutaneous Interventions Using Large-Bore Catheters.JAMA Cardiol2017https://conductscience.org/library/papers/28315573PubMed
330621982Transcatheter Aortic Valve Replacement in Oncology Patients With Severe Aortic Stenosis.JACC Cardiovasc Interv2019https://conductscience.org/library/papers/30621982PubMed
430065928Access Sites for TAVI: Patient Selection Criteria, Technical Aspects, and Outcomes.Front Cardiovasc Med2018https://conductscience.org/library/papers/30065928PubMed
52272640030 days and midterm outcomes of patients undergoing percutaneous replacement of aortic valve according to their renal function: a multicenter study.Int J Cardiol2013https://conductscience.org/library/papers/22726400PubMed
636153179The Usefulness of the Modified Essential Frailty Toolset to Predict Late Bleeding Events after Transcatheter Aortic Valve Implantation.Am J Cardiol2022https://conductscience.org/library/papers/36153179PubMed
731116032Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention.Circulation2019https://conductscience.org/library/papers/31116032PubMed
827026020
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.
Circulation2016https://conductscience.org/library/papers/27026020PubMed
922083020Transcatheter aortic valve implantation: current and future approaches.Nat Rev Cardiol2011https://conductscience.org/library/papers/22083020PubMed
1024657695Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.J Am Coll Cardiol2014https://conductscience.org/library/papers/24657695PubMed
1128965713Predictors of 1-Year Mortality After Transcatheter Aortic Valve Implantation in Patients With and Without Advanced Chronic Kidney Disease.Am J Cardiol2017https://conductscience.org/library/papers/28965713PubMed
1220961243Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med2010https://conductscience.org/library/papers/20961243PubMed
1327040324Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.N Engl J Med2016https://conductscience.org/library/papers/27040324PubMed
1423707321Prognostic value of chronic kidney disease after transcatheter aortic valve implantation.J Am Coll Cardiol2013https://conductscience.org/library/papers/23707321PubMed
1527053442Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis.Lancet2016https://conductscience.org/library/papers/27053442PubMed
1632727528Influence of transcatheter aortic valve replacement on patients with severe aortic stenosis undergoing non-cardiac surgery.J Cardiothorac Surg2020https://conductscience.org/library/papers/32727528PubMed
1736211566Are cardiovascular comorbidities always associated with a worse prognosis in patients with lung cancer?Front Cardiovasc Med2022https://conductscience.org/library/papers/36211566PubMed
1827142257Baseline anemia and its impact on midterm outcome after transcatheter aortic valve implantation.Catheter Cardiovasc Interv2017https://conductscience.org/library/papers/27142257PubMed
1930883058Transcatheter Aortic-Valve Replacement with a Balloon-Expandable Valve in Low-Risk Patients.N Engl J Med2019https://conductscience.org/library/papers/30883058PubMed
2036599591No Antithrombotic Therapy After Transcatheter Aortic Valve Replacement: Insight From the OCEAN-TAVI Registry.JACC Cardiovasc Interv2023https://conductscience.org/library/papers/36599591PubMed

See all 131 referencesDownload CSV of references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.

PMIDTitleJournalYearIn PapersSource
42356150Transcatheter Aortic Valve Implantation in Cancer Patients: A Contemporary Review of the Specific Challenges, the Outcomes, Risk Stratification, and Decision-Making.Medicina (Kaunas)2026https://conductscience.org/library/papers/42356150PubMed
41827184Thrombotic Versus Bleeding Risk After Transcatheter Aortic Valve Implantation.J Clin Med2026https://conductscience.org/library/papers/41827184PubMed
41367365Nationwide Analysis of PCI After TAVR From the Netherlands Heart Registration.Catheter Cardiovasc Interv2026https://conductscience.org/library/papers/41367365PubMed
41156021Definition, Incidence, Prediction, and Prevention of Bleeding Events After Transcatheter Aortic Valve Implantation.J Clin Med2025https://conductscience.org/library/papers/41156021PubMed
40958622An ongoing quest to discern the optimal antithrombotic therapy after TAVI.EuroIntervention2025https://conductscience.org/library/papers/40958622PubMed
40958621VARC-HBR criteria validation in TAVI patients on oral anticoagulation.EuroIntervention2025https://conductscience.org/library/papers/40958621PubMed
40819859
Rationale and design of SCOPE trial: a prospective, multicentre, open-label, randomised controlled trial to evaluate the overall efficacy and safety of a short-term anticoagulation strategy versus conventional single antiplatelet therapy in patients with severe aortic stenosis without indications for anticoagulation or dual antiplatelet therapy post-transcatheter aortic valve replacement.
BMJ Open2025https://conductscience.org/library/papers/40819859PubMed
40430236Complex Transfemoral Access During Transcatheter Aortic Valve Replacement: A Narrative Review of Management, Complexity Scores, and Alternative Access.Life (Basel)2025https://conductscience.org/library/papers/40430236PubMed
40118800Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement.J Am Heart Assoc2025https://conductscience.org/library/papers/40118800PubMed
39475194Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR.Circ Cardiovasc Interv2025https://conductscience.org/library/papers/39475194PubMed
39252142Outcomes of patients with active cancer after transcatheter aortic valve replacement: an updated meta-analysis.Cardiooncology2024https://conductscience.org/library/papers/39252142PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38726720

GET https://conductscience.org/api/papers/v1/38726720/authors?page=2